Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (5.351)

1

Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma : a post-marketing surveillance study

enthalten in: Japanese journal of clinical oncology | 2019

von Motoo, N. | Hayashi, Y. | Shimizu, A. | +2

2

A Case of Nephrotic Syndrome Induced by FOLFIRI plus Ramucirumab for Metastatic Descending Colon Cancer

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2019

von Shingai, T. | Fukuzaki, T. | Okimura, S. | +8

3

Atezolizumab First-Line Combination Therapy : A Review in Metastatic Nonsquamous NSCLC

enthalten in: Targeted oncology | 2019

von Dhillon, S. | Syed, Y.

4

Predictive Value of OCT-Controlled Early Response of Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Bevacizumab Therapy

enthalten in: Klinische Monatsblatter fur Augenheilkunde | 2019

von Kourakos, V. | Rauscher, A. | Schmidbauer, J.

5

First-line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non-small cell lung cancer : A United States-based cost-effectiveness analysis

enthalten in: Cancer | 2019

von Wan, X. | Luo, X. | Tan, C. | +3

6

Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity

enthalten in: Seminars in perinatology | 2019

von VanderVeen, D. | Cataltepe, S.

7

Clear-cell Renal Cell Carcinoma : Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors

enthalten in: Clinical genitourinary cancer | 2019

von Verbiest, A. | Renders, I. | Caruso, S. | +17

8

State of art of advanced triple negative breast cancer

enthalten in: The breast journal | 2019

von Khosravi-Shahi, P. | Cabezón-Gutiérrez, L. | Aparicio Salcedo, M.

9

Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer in the United States

enthalten in: JAMA network open | 2019

von Criss, S. | Mooradian, M. | Watson, T. | +3

CommentIn: JAMA Netw Open. 2019 Sep 4;2(9):e1911913. - PMID 31553464

10

Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma

enthalten in: European urology | 2019

von Albiges, L. | Powles, T. | Staehler, M. | +16

CommentIn: Eur Urol. 2020 Mar;77(3):e76-e77. - PMID 31610901

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[536]